Hepatitis Monthly

Published by: Kowsar

Lack of Association Between Transforming Growth Factor Beta 1 -509C/T and +915G/C Polymorphisms and Chronic Hepatitis B in Iranian Patients

Armin Hosseini Razavi 1 , 2 , Pedram Azimzadeh 1 , Seyed Reza Mohebbi 1 , * , Seyed Masoud Hosseini 2 , * , Sara Romani 1 , Mahsa Khanyaghma 1 , Yasin Hatami 1 , 3 , Afsaneh Sharifian 1 and Mohammad Reza Zali 1
Authors Information
1 Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Microbiology, Faculty of Biological Sciences, Shahid Beheshti University, Tehran, IR Iran
3 Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Corresponding Authors:
Article information
  • Hepatitis Monthly: April 2014, 14 (4); e13100
  • Published Online: April 7, 2014
  • Article Type: Research Article
  • Received: June 21, 2013
  • Revised: November 2, 2013
  • Accepted: November 26, 2013
  • DOI: 10.5812/hepatmon.13100

To Cite: Hosseini Razavi A, Azimzadeh P, Mohebbi S R, Hosseini S M, Romani S, et al. Lack of Association Between Transforming Growth Factor Beta 1 -509C/T and +915G/C Polymorphisms and Chronic Hepatitis B in Iranian Patients, Hepat Mon. 2014 ;14(4):e13100. doi: 10.5812/hepatmon.13100.

Copyright: Copyright © 2014, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Damavand B, Azimzadeh P, Derakhshan F, et al. Characterization of hepatitis B virus genome variability in Iranian patients with chronic infection, a nationwide study. J Med Virol. 2012; 84(3): 414-23[DOI][PubMed]
  • 2. Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Noorinayer B, Derakhshan F, Chiani M, et al. Molecular epidemiology of hepatitis B virus in Iran. Clin Microbiol Infect. 2008; 14(9): 858-66[DOI][PubMed]
  • 3. Dienstag JL. Hepatitis B virus infection. N Engl J Med. 2008; 359(14): 1486-500[DOI][PubMed]
  • 4. Kao JH. Molecular epidemiology of hepatitis B virus. Korean J Intern Med. 2011; 26(3): 255-61[DOI][PubMed]
  • 5. Mohebbi SR, Sanati A, Cheraghipour K, Rostami Nejad M, Shalmani HM, Zali MR. Hepatitis C and hepatitis B virus infection: epidemiology and risk factors in a large cohort of pregnant women in Lorestan, West of Iran. Hepat Mon. 2011; 11(9): 736-9[DOI][PubMed]
  • 6. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007; 45(2): 507-39[DOI][PubMed]
  • 7. Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris). 2010; 58(4): 258-66[DOI][PubMed]
  • 8. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009; 49(5 Suppl)-55[DOI][PubMed]
  • 9. Chou YC, Chen ML, Hu CP, Chen YL, Chong CL, Tsai YL, et al. Transforming growth factor-beta1 suppresses hepatitis B virus replication primarily through transcriptional inhibition of pregenomic RNA. Hepatology. 2007; 46(3): 672-81[DOI][PubMed]
  • 10. Hong MH, Chou YC, Wu YC, Tsai KN, Hu CP, Jeng KS, et al. Transforming growth factor-beta1 suppresses hepatitis B virus replication by the reduction of hepatocyte nuclear factor-4alpha expression. PLoS One. 2012; 7(1)[DOI][PubMed]
  • 11. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol. 1987; 105(3): 1039-45[PubMed]
  • 12. Buckova D, Izakovicova Holla L, Benes P, Znojil V, Vacha J. TGF-beta1 gene polymorphisms. Allergy. 2001; 56(12): 1236-7[PubMed]
  • 13. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet. 1999; 8(1): 93-7[PubMed]
  • 14. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation. 1998; 66(8): 1014-20[PubMed]
  • 15. Crilly A, Hamilton J, Clark CJ, Jardine A, Madhok R. Analysis of transforming growth factor beta1 gene polymorphisms in patients with systemic sclerosis. Ann Rheum Dis. 2002; 61(8): 678-81[PubMed]
  • 16. Gewaltig J, Mangasser-Stephan K, Gartung C, Biesterfeld S, Gressner AM. Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis. Clin Chim Acta. 2002; 316(1-2): 83-94[PubMed]
  • 17. Kim SJ, Glick A, Sporn MB, Roberts AB. Characterization of the promoter region of the human transforming growth factor-beta 1 gene. J Biol Chem. 1989; 264(1): 402-8[PubMed]
  • 18. Hosseini Razavi A, Hosseini SM, Azimzadeh P, Mohebbi SR, Khanyaghma M, Sharifian A, et al. The Assosiation of Promoter Polymorphism of TGF-β1 (-509C>T) with Chronic Hepatitis B in Iraninan Patients Referred to Taleghani Hospital, Tehran.; 2013;
  • 19. Liberek A, Jakobkiewicz-Banecka J, Kloska A, Swiderska J, Marek A, Luczak G, et al. [Gene polymorphism of transforming growth factor beta1 (TGF-beta1) in the pathogenesis and clinical course of chronic hepatitis in children]. Med Wieku Rozwoj. 2009; 13(3): 171-9[PubMed]
  • 20. Pereira FA, Pinheiro da Silva NN, Rodart IF, Carmo TM, Lemaire DC, Reis MG. Association of TGF-beta1 codon 25 (G915C) polymorphism with hepatitis C virus infection. J Med Virol. 2008; 80(1): 58-64[DOI][PubMed]
  • 21. Romani S, Azimzadeh P, Mohebbi SR, Kazemian S, Almasi S, Naghoosi H, et al. Investigation of Transforming Growth Factor-beta1 Gene Polymorphisms Among Iranian Patients With Chronic Hepatitis C. Hepat Mon. 2011; 11(11): 901-6[DOI][PubMed]
  • 22. Suzuki S, Tanaka Y, Orito E, Sugauchi F, Hasegawa I, Sakurai M, et al. Transforming growth factor-beta-1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol. 2003; 18(10): 1139-43[PubMed]
  • 23. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med. 2003; 198(12): 1875-86[DOI][PubMed]
  • 24. Yang G, Liu A, Xie Q, Guo TB, Wan B, Zhou B, et al. Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B. Int Immunol. 2007; 19(2): 133-40[DOI][PubMed]
  • 25. Mills KH. Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol. 2004; 4(11): 841-55[DOI][PubMed]
  • 26. Park KH, Lo Han SG, Whang YM, Lee HJ, Yoo YD, Lee JW, et al. Single nucleotide polymorphisms of the TGFB1 gene and lung cancer risk in a Korean population. Cancer Genet Cytogenet. 2006; 169(1): 39-44[DOI][PubMed]
  • 27. Khorramdelazad H, Hassanshahi G, Nasiri Ahmadabadi B, Kazemi Arababadi M. High Serum Levels of TGF-beta in Iranians With Chronic HBV Infection. Hepat Mon. 2012; 12(11)[DOI][PubMed]
  • 28. Falleti E, Fabris C, Toniutto P, Fontanini E, Cussigh A, Bitetto D, et al. TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer. Cytokine. 2008; 44(2): 256-61[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader